|
|
|
|
|
| Driven by the emergence of innovative technologies such as microfluidics, genomics, high throughput screening and proteomics, world market for drug discovery technologies is projected to reach $57.7 billion by 2012. Despite the heavy costs involved in discovery of new drugs, investments in pharmaceutical research and development are reaching new highs encouraged by evolving medical standards, favorable demographic trends and shifting preferences of the medical community towards technologically advanced products. |
|
|
| Fast and affordable program leads to 3 national certifications and prepares grads for a variety of in-demand clinical medical positions. |
|
|
| Capgemini to provide comprehensive, collaborative approach to streamline, align, and enhance National Institutes of Health (NIH) capital planning and investment control |
|
|
| Comprehensive tutorials on the DBTSS, Pfam and PDB databases enable
researchers to quickly and effectively use these invaluable resources. |
|
|
| Global biochips market is forecast to experience robust growth and is on course to reach $3.4 billion by 2012. Aging population, third party reimbursement, and a growing number of individuals suffering from common chronic diseases represent the key market drivers. |
|
|
| MyNetResearch.com™, the leading global collaborative research community, announces the winners of its 2008 Doctoral Students Research Competition . |
|
|
| BioDiscovery Inc., the leading developer of integrated software solutions for microarray-based research, announced today that the Johns Hopkins Medical Institute has acquired a multi-seat license of Nexus Expression, a new intuitive and powerful tool for microarray gene expression analysis. |
|
|
| CorporateSNOBS.com has added corporate gifts to support breast cancer reasearch. During October, the month where traditionally people come together to build support for research, CorporateSNOBS will be continuing to offer their line of Pink Ribbon Products. |
|
|
| Jana Wiggins, President & CEO of Document Advantage Corporation ,(DocuVantage), has been named a finalist for the 2008 Tampa Bay CEO of the Year award in the Business Products & Services category. The finalists and winners will be celebrated by Tampa Bay CEO Magazine, the awards program host, at a gala dinner on December 11 at the Pepin Hospitality Center in Tampa. |
|
|
| CureTogether to demonstrate at Health 2.0 Conference how some patients
are responding to inadequate research by doing it themselves. |
|
|
